Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PSTV stock hub

Plus Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PSTVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PSTV

In the news

Latest news · PSTV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PSTV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001095981
Company name	Plus Therapeutics, Inc.
Country	United States
Country code	US
Cusip	72941H806
Employees	28
Employees Change	7%
Employees Change Percent	33.33
Enterprise value	$34.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US72941H8060
Last refreshed	2026-05-10
Market cap	$42M
Market cap category	Nano-Cap
Price	$6.12
Price currency	USD
Rev Per Employee	186,178.57x
Sector	Healthcare
Sic	3841
Symbol	PSTV
Website	https://plustherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-53.31%
EV Sales Forward	5.8x
EV/Sales	6.56x
FCF yield	-49.63%
P/B ratio	8.5x
P/S ratio	8.06x
PS Forward	7.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-293.46%
EBITDA Margin	-284.92%
Gross margin	-60.73%
Gross Profit	$-3.2M
Net Income	$-22.4M
Net Income Growth Years	0%
Pretax Margin	-429.43%
Profit Per Employee	$-799,500
ROA	-83.29
Roa5y	-66.17
ROCE	-381.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-68.82%
Cagr15y	-62.91%
Cagr1y	-56.59%
Cagr20y	-53.01%
Cagr3y	-60.55%
Cagr5y	-62.4%
EPS Growth Years	11
Revenue Growth	-10.49x
Revenue Growth Q	-3.19x
Revenue Growth Years	0x
Revenue Growth3 Y	185.5x
Revenue Growth5 Y	76.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.45
Assets	$16.3M
Cash	$8.6M
Current Assets	$15.2M
Current Liabilities	$12.3M
Debt	$821,000
Debt Equity	$0.21
Equity	$4M
Interest Coverage	-27.92
Liabilities	$12.3M
Long Term Assets	$1.2M
Long Term Liabilities	$15,000
Net Cash	$7.8M
Net Cash By Market Cap	$18.55
Net Cash Growth	3,159.83%
Net Debt Equity	$-1.95
Tangible Book Value	$3.3M
Tangible Book Value Per Share	$0.59
WACC	12.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.23
Net Working Capital	$-5M
Quick ratio	0.73
Working Capital	$2.9M
Working Capital Turnover	$-1.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-910.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-56.56%
200-day SMA	11.12
3Y total return	-93.86%
50-day SMA	6.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.25%
All Time High	28,149,606.3
All Time High Change	-100%
All Time High Date	2005-12-19
All Time Low	2.9
All Time Low Change	111.03%
All Time Low Date	2026-04-07
ATR	0.64
Beta	1.4
Beta1y	2.39
Beta2y	1.52
Ch YTD	-52.22
High	6.3
High52	23.43
High52 Date	2025-10-06
High52ch	-73.87%
Low	5.82
Low52	2.9
Low52 Date	2026-04-07
Low52ch	111.03%
Ma50ch	1.27%
Premarket Change Percent	3.7
Premarket Price	$6.17
Premarket Volume	7,528
Price vs 200-day SMA	-44.94%
RSI	51.16
RSI Monthly	30.61
RSI Weekly	39.24
Sharpe ratio	0.22x
Sortino ratio	0.4
Total Return	-910.35%
Tr YTD	-52.22
Tr15y	-100%
Tr1m	109.59%
Tr1w	0.49%
Tr3m	-5.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	1
Analyst Price Target Top	$25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.88
Earnings Revenue Estimate	969,200x
Earnings Revenue Estimate Growth	-8.48x
Operating Income	$-15.3M
Operating margin	-293.5
Price target	$55
Price Target Change	$799
Price Target Change Top	$308

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,325,048%
Float Percent	92.17%
Net Borrowing	-2,507,000
Shares Insiders	0.62%
Shares Institutions	7.73%
Shares Out	6,862,027
Shares Qo Q	28.16%
Shares Yo Y	910.35%
Short Float	21.31%
Short Ratio	2.49
Short Shares	19.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-22.4M
Average Volume	273,782.9x
Bv Per Share	0.72
CAPEX	$-67,000
Ch10y	-100
Ch15y	-100
Ch1m	109.6
Ch1w	0.49
Ch1y	-56.56
Ch20y	-100
Ch3m	-5.82
Ch3y	-93.86
Ch5y	-99.25
Ch6m	-54.51
Change	2.86%
Change From Open	1.32
Close	5.95
Days Gap	1.51
Depreciation Amortization	445,000
Dollar Volume	652,073.8
Earnings Date	2026-05-29
Earnings Time	amc
EBIT	$-15.3M
EBITDA	$-14.9M
EPS	$-7.25
F Score	3
FCF	$-20.8M
FCF EV Yield	-60.93x
FCF Per Share	$-3.04
Financing CF	30,311,000
Fiscal Year End	December
Founded	1,996
Goodwill	372,000
Investing CF	-854,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2026-04-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	10.3
Ma150ch	-40.55%
Ma20	6.26
Ma20ch	-2.19%
Net CF	8,682,000
Next Earnings Date	2026-05-29
Open	6.04
Optionable	No
Position In Range	62.5
Post Close	6.12
Postmarket Change Percent	-0.33
Postmarket Price	$6.1
Ppne	327,000
Pre Close	5.95
Price Date	2026-05-08
Ptbv Ratio	12.76
Relative Volume	0.39x
Revenue	5,213,000x
SBC By Revenue	29.54x
Share Based Comp	1,540,000
Tr20y	-100%
Tr6m	-54.51%
Us State	Texas
Volume	106,548
Z Score	-45.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PSTV pay a dividend?

Capital-return profile for this ticker.

Performance

PSTV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PSTV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.7%

Float: +92.2% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PSTV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.2

Neutral momentum band

Price vs 200-day MA

-44.9%

50/200-day relationship not available

Beta (5Y)

1.40

More volatile than the market

Sharpe ratio

0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PSTV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PSTV stock rating?

Plus Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PSTV analysis?

The full report lives at /stocks/PSTV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PSTV?

The latest report frames PSTV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PSTV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.